Ellis Investment Partners, LLC Haemonetics Corp Transaction History
Ellis Investment Partners, LLC
- $495 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
347Shares Held
51.8MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$384 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$334 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$285 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$273 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$165 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.31B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...